Posted by Michael Wonder on 05 Aug 2015

Approval of proposal for paliperidone, risperidone and olanzapine depot injections

25 March 2014 - PHARMAC is pleased to announce the approval of a proposal to:

• fund paliperidone depot injection (Invega Sustenna) from 1 May 2014 in conjunction with a price decrease on risperidone depot injection (Risperdal Consta), through an agreement with Janssen-Cilag Pty Ltd (Janssen); and

• amend the restrictions for risperidone depot injection and olanzapine depot injection (Zyprexa Relprevv) from 1 May 2014.

This proposal was the subject of a consultation letter dated 13 February 2014, available online at http://www.pharmac.health.nz/news/consultation-2014-02-13-palperidone/

For more details, go to: http://www.pharmac.health.nz/news/notification-2014-03-25-paliperidone/

Posted by:

Michael Wonder

Posted in: